{"id":"https://openalex.org/W30609453","doi":null,"title":"Update on lipids and C-reactive protein in acute and chronic coronary heart disease.","display_name":"Update on lipids and C-reactive protein in acute and chronic coronary heart disease.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W30609453","mag":"30609453","pmid":"https://pubmed.ncbi.nlm.nih.gov/20548807","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2879197"},"language":"en","primary_location":{"id":"pmid:20548807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20548807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Texas Heart Institute journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2879197/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104707466","display_name":"Peter H. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peter H Jones","raw_affiliation_strings":["Baylor College of Medicine, Methodist DeBakey Heart & Vascular Center, Houston, Texas 77030, USA. jones@bcm.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Methodist DeBakey Heart & Vascular Center, Houston, Texas 77030, USA. jones@bcm.edu","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5104707466"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00363344,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"3","first_page":"307","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8500000238418579},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8270000219345093},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.7929999828338623},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.8479999899864197},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.628000020980835},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.7929999828338623},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9259999990463257},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cholesterol-absorption-inhibitors","display_name":"cholesterol absorption inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/niacin","display_name":"nicotinic acid","score":0.8840000033378601},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":1.0},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8149999976158142},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9039999842643738},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.7179999947547913},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.5260000228881836},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9810000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9256628751754761},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.5904245376586914},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.5750786662101746},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5468950867652893},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4666350483894348},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4276665449142456},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2777128219604492}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:20548807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20548807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Texas Heart Institute journal","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2879197","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2879197/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tex Heart Inst J","raw_type":"Text"},{"id":"mag:30609453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20548807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2879197","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2879197/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tex Heart Inst J","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W71404102","https://openalex.org/W201549064","https://openalex.org/W1242386148","https://openalex.org/W1812416290","https://openalex.org/W2081615427","https://openalex.org/W2130813021","https://openalex.org/W3022401702"],"related_works":["https://openalex.org/W2036258772","https://openalex.org/W1697900186","https://openalex.org/W2400233210","https://openalex.org/W2418375869","https://openalex.org/W2140332812","https://openalex.org/W1527469372","https://openalex.org/W2022884334","https://openalex.org/W2468078881","https://openalex.org/W2110750045","https://openalex.org/W2004549060"],"abstract_inverted_index":{"For":[0],"the":[1,22,27,44,71,107,120,196,200,390,518,558,566,609,634,655,708,713,725,741,746,754,767,796,807,833,842,856,874,886,900,926,959,987,1002,1016],"prevention":[2,186,572,715,960],"of":[3,14,21,33,46,54,74,96,98,109,171,180,193,297,392,444,460,505,532,540,553,557,589,625,629,636,657,672,710,744,748,756,801,810,902,925,961,989,1006],"first":[4],"and":[5,12,59,91,130,140,283,289,300,327,345,409,429,513,517,576,579,701,789,799,864,916,929,963,982,1011],"recurrent":[6,964],"cardiovascular":[7],"disease":[8,57,395,418,911],"(CVD)":[9],"events,":[10],"identification":[11],"treatment":[13,103,143,835,953,1008],"dyslipidemia":[15,341],"in":[16,51,149,301,317,331,365,402,415,437,475,490,608,619,642,679,707,712,790,841,873,884,958,1000,1027],"at-risk":[17,208,333],"individuals":[18,187,209,337,644],"is":[19,101,447,468,478,486,525,550,667,954],"one":[20,556],"most":[23,258,559],"important":[24,560,956],"approaches.":[25],"Over":[26],"past":[28],"2":[29,355,591,627,814],"decades,":[30],"a":[31,114,168,272,441,457,603,616,623,670,677,691,837,852,870],"wealth":[32],"randomized":[34,594,812],"clinical":[35,422,1029],"trial":[36,770,829,879],"(RCT)":[37],"data":[38,225,238,251,498],"has":[39,66],"consistently":[40],"confirmed":[41],"that":[42,157,227,253,280,523,548,665,832,888,933],"reducing":[43,899,914],"number":[45],"atherogenic":[47,75],"lipid":[48,154,213,363,750,803,808,1007],"particles":[49],"results":[50,519,924],"lower":[52,284,897],"rates":[53],"coronary":[55,173,462,942],"heart":[56,405],"(CHD)":[58],"stroke":[60],"events.":[61,966],"Although":[62],"low-density-lipoprotein":[63],"cholesterol":[64,87,890],"(LDL-C)":[65],"generally":[67],"been":[68,119,199,360,435,882],"designated":[69],"as":[70,85,113,127,146,161,216,287,306,425,613,615,640,740,973,975,980,994],"surrogate":[72],"measure":[73],"particles,":[76],"other":[77,212,476,702,920,977],"measures":[78,100,978],"are":[79,206,239,243,267,291,499,646,985],"probably":[80],"even":[81],"better":[82],"predictors,":[83],"such":[84,126,160,215,286,424,639,979,993],"non-high-density-lipoprotein":[86],"(HDL-C),":[88],"apolipoprotein":[89,983],"B,":[90,984],"NMR-derived":[92],"particle":[93,322],"member.1":[94],"Regardless":[95],"which":[97,335,484],"these":[99,203],"used,":[102],"with":[104,151,362,492,538,858,892,949],"statins":[105,117,316,379,387,397,410,736,893,936],"lowers":[106],"level":[108,482],"each":[110],"measure,":[111],"and,":[112],"drug":[115],"class,":[116],"have":[118,164,176,189,198,211,339,353,359,371,433,453,663,719,737,775,881],"preferred":[121],"therapeutic":[122],"choice.":[123],"Other":[124],"drugs,":[125],"bile-acid":[128],"resins":[129],"cholesterol-absorption":[131],"inhibitors,":[132],"can":[133,141,471,651,944],"reduce":[134,321,389,399,412],"LDL-C":[135,178,191,442,470,481,530,587,765,971],"(less":[136],"effectively":[137],"than":[138,534,542,650,896],"statins)":[139],"be":[142,472,563,652,676,1025],"options,":[144],"either":[145,779,818],"monotherapy":[147,742,822],"or":[148,167,221,313,352,456,597,783,823,1004],"combination":[150,749,834],"statins.":[152],"National":[153,308,726],"guidelines":[155,309,733,1018],"recommend":[156,310],"high-risk":[158,184],"individuals,":[159],"those":[162,346],"who":[163,210,338,347,452,584,645,774],"stable":[165,454],"CHD":[166,455,772],"recent":[169,458,683,878],"history":[170,459],"acute":[172,461],"syndrome,":[174],"should":[175,188,1024],"an":[177,190,480,722,763,955],"goal":[179,192,443,968],"<70":[181,445],"mg/dL,":[182,544],"while":[183],"primary":[185,571,714,844,875],"<100":[194],"mg/dL.\r\n\r\nAlthough":[195],"RCTs":[197,269,358,561],"basis":[201,656],"for":[202,247,274,325,380,449,529,690,694,970,976],"guidelines,":[204],"there":[205,242,266,479,485,524,549],"many":[207],"risks,":[214],"low":[217,427,776],"HDL-C,":[218],"high":[219,254,431],"triglycerides,":[220,285,432],"both.":[222],"Some":[223,420,661],"observational":[224,250],"indicate":[226],"increasing":[228],"HDL-C":[229,245,282,330,428,777,865],"contributes":[230],"to":[231,270,315,319,328,388,398,411,562,595,720,724,761,780,784,792,819,824,1015,1019],"CVD":[232,264,375,400,413,488,611,965],"risk":[233,649,659,673,711],"reduction;":[234],"but":[235,368,674],"because":[236,296],"RCT":[237,497],"very":[240,998],"limited,":[241],"no":[244,268,551],"goals":[246],"treatment.":[248,630],"Similarly,":[249],"suggest":[252,520,932],"triglyceride":[255,860],"levels":[256,531,539,588,778,861,866],"(in":[257],"cases,":[259],">150":[260],"mg/dL)":[261],"confer":[262],"significant":[263,605,848,871],"risk\u2014yet":[265],"demonstrate":[271],"benefit":[273,489,528,798],"treating":[275,802],"triglycerides":[276],"specifically.":[277],"The":[278,495,923],"drugs":[279],"increase":[281,329],"niacin":[288,312],"fibrates,":[290],"not":[292,372,434,521,668,687],"considered":[293],"first-line":[294],"treatments":[295],"their":[298],"slight,":[299],"some":[302,526,877],"cases":[303],"neutral,":[304],"effects":[305],"monotherapy.":[307],"adding":[311],"fibrates":[314],"order":[318,760,791],"further":[320],"numbers":[323],"(non-HDL-C,":[324],"example)":[326],"appropriate":[332],"people,":[334],"includes":[336],"mixed":[340],"(or":[342,1009],"cardiometabolic":[343],"risk)":[344],"meet":[348],"metabolic":[349],"syndrome":[350],"criteria":[351],"type":[354,813],"diabetes":[356,815],"mellitus.\r\n\r\nSeveral":[357],"performed":[361],"therapies":[364],"special":[366,421],"populations,":[367],"they":[369],"unfortunately":[370],"demonstrated":[373],"any":[374,847],"benefit.":[376],"These":[377],"include":[378],"preventing":[381],"aortic":[382],"stenosis":[383],"progression":[384,391],"(SEAS,":[385],"ASTRONOMER),":[386],"mild":[393],"Alzheimer's":[394],"(LEADe),":[396],"events":[401,414],"class":[403],"III\u2013IV":[404],"failure":[406],"(GISSI-HF,":[407],"CORONA),":[408],"end-stage":[416],"renal":[417],"(AURORA).":[419],"conditions,":[423],"isolated":[426,430],"tested":[436],"RCTs.\r\n\r\nAs":[438],"mentioned":[439],"above,":[440],"mg/dL":[446,536,863,868],"reasonable":[448],"all":[450,919],"people":[451],"syndrome.":[463],"A":[464],"frequent":[465],"safety":[466,800,849],"question":[467],"whether":[469],"too":[473],"low:":[474],"words,":[477],"at":[483,647],"little":[487],"comparison":[491],"non-CVD":[493],"risk?":[494],"available":[496],"drawn":[500],"from":[501],"post":[502],"hoc":[503],"analyses":[504],"intensive":[506],"versus":[507],"standard":[508,743,988],"statin":[509,781,785,821,825,907,952],"therapy":[510,751],"(the":[511],"TNT":[512],"PROVE":[514],"IT":[515],"trials),":[516],"only":[522,626,669],"incremental":[527,797],"less":[533],"50":[535],"compared":[537,948],"greater":[541],"80":[543],"but,":[545],"more":[546,895],"importantly,":[547],"evidence":[552],"noncardiovascular":[554],"detriment.\r\n\r\nRecently,":[555],"reported":[564],"was":[565],"JUPITER":[567],"trial.2":[568],"In":[569,759,851],"this":[570,1022],"study,":[573],"17,802":[574],"men":[575],"women":[577],"(>50":[578],">60":[580],"years":[581,628],"old,":[582],"respectively)":[583],"had":[585,869],"baseline":[586,859],"mg/L":[592],"were":[593],"placebo":[596],"rosuvastatin":[598],"20":[599],"mg/day.":[600],"It":[601],"revealed":[602],"highly":[604],"(44%)":[606],"reduction":[607,618,840,872],"composite":[610,843],"endpoint,":[612,845],"well":[614,974],"20%":[617],"all-cause":[620],"death,":[621],"after":[622],"mean":[624],"This":[631,828],"result":[632],"highlighted":[633],"potential":[635],"novel":[637],"biomarkers,":[638,992],"hs-CRP,":[641,995],"identifying":[643],"higher":[648],"predicted":[653],"on":[654,795],"traditional":[658],"factors.":[660],"investigators":[662],"suggested":[664],"CRP":[666],"marker":[671],"might":[675,705,909,996],"participant":[678],"promoting":[680],"atherosclerosis.":[681],"Several":[682],"publications,3-5":[684],"however,":[685],"do":[686],"provide":[688],"support":[689],"causative":[692],"role":[693,699,747],"CRP.":[695],"To":[696],"see":[697],"what":[698],"hs-CRP":[700],"candidate":[703],"biomarkers":[704],"play":[706],"assessment":[709],"setting,":[716],"we":[717,1012],"shall":[718],"await":[721,753,1013],"update":[723],"Cholesterol":[727],"Education":[728],"Program":[729],"Adult":[730],"Treatment":[731],"Panel":[732],"(ATP":[734],"IV).\r\n\r\nAlthough":[735],"established":[738],"themselves":[739],"care,":[745],"must":[752],"conclusion":[755],"ongoing":[757],"RCTs.":[758],"achieve":[762],"optimal":[764,820],"goal,":[766],"AIM":[768],"HIGH":[769],"randomizes":[771],"patients":[773,817],"alone":[782],"plus":[786,826],"extended-release":[787],"niacin;":[788],"shed":[793],"light":[794],"abnormalities":[804],"beyond":[805],"LDL-C,":[806],"arm":[809],"ACCORD6":[811],"mellitus":[816],"fenofibrate.":[827],"recently":[830],"showed":[831],"produced":[836],"nonsignificant":[838],"8%":[839],"without":[846],"issues.":[850],"pre-specified":[853],"subgroup":[854],"analysis,":[855],"subjects":[857],">204":[862],"<34":[867],"endpoint.6\r\n\r\nFinally,":[876],"data6,7":[880],"useful":[883,999],"exploring":[885],"concept":[887],"inhibiting":[889],"synthesis":[891],"does":[894],"LDL-C:":[898],"prenylation":[901],"certain":[903],"small":[904],"G-proteins":[905],"via":[906],"use":[908],"improve":[910,945],"outcomes":[912],"by":[913],"inflammation":[915],"favorably":[917],"altering":[918],"cellular":[921],"functions.":[922],"NAPLES":[927],"II7":[928],"ARMYDA-RECAPTURE8":[930],"trials":[931],"giving":[934],"high-dose":[935],"within":[937],"24":[938],"hours":[939],"before":[940],"percutaneous":[941],"intervention":[943],"30-day":[946],"outcomes,":[947],"placebo.\r\n\r\nIn":[950],"conclusion,":[951],"mainstay":[957],"1st":[962],"Intensive":[967],"attainment":[969],"levels,":[972],"non-HDL-C":[981],"now":[986],"care.":[990],"Novel":[991],"prove":[997],"guiding":[1001],"initiation":[1003],"intensification":[1005],"both),":[1010],"updates":[1014],"national":[1017],"determine":[1020],"how":[1021],"approach":[1023],"used":[1026],"daily":[1028],"practice.":[1030]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}